Autolus Therapeutics plc Other Assets
Autolus Therapeutics plc (AUTL) had Other Assets of $2.18 million as of 2022-12-31, per its 20-F filed 2023-03-07.
Discontinued › Balance Sheet › Assets
us-gaap:OtherAssets · last filed 2023-03-07
- 2022-12-31: Other Assets $2.18M.
- 2021-12-31: Other Assets $2.36M.
- 2020-12-31: Other Assets $3.03M.
- 2019-12-31: Other Assets $0.00.
| Period end | Other Assets |
|---|---|
| 2022-12-31 | $2.18M 20-F · filed 2023-03-07 |
| 2021-12-31 | $2.36M 20-F · filed 2023-03-07 |
| 2020-12-31 | $3.03M 20-F · filed 2022-03-10 |
| 2019-12-31 | $0.00 20-F · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 |